tranylcypromine has been researched along with fluoxetine in 35 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (14.29) | 18.7374 |
| 1990's | 10 (28.57) | 18.2507 |
| 2000's | 14 (40.00) | 29.6817 |
| 2010's | 6 (17.14) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ | 1 |
| Baker, GB; Robertson, B; Vanderwolf, CH | 1 |
| Morse, S; Muir, C; Spiller, HA | 1 |
| Boyer, WF; Feighner, JP; Neborsky, RJ; Tyler, DL | 1 |
| Hudson, JI; Keck, PE; McElroy, SL; Pope, HG | 1 |
| Sternbach, H | 1 |
| Smith, DF | 1 |
| Lalonde, R; Vikis-Freibergs, V | 1 |
| Jones, RS | 1 |
| Gard, PR; Mandy, A; Meakin, AJ; Nickels, DP; Whiting, JM | 1 |
| Ruiz, F | 1 |
| Beasley, CM; Heiligenstein, JH; Masica, DN; Wheadon, DE; Zerbe, RL | 1 |
| Duman, RS; Nestler, EJ; Nibuya, M | 1 |
| Erfurth, A; Wurtman, RJ | 1 |
| Gard, PR; Mandy, A; Sutcliffe, MA | 1 |
| Duman, RS; Impey, S; Sakai, N; Shin, K; Steffen, C; Storm, D; Thome, J; Zhang, YJ | 1 |
| Diaz, J; Lammers, CH; Schwartz, JC; Sokoloff, P | 1 |
| Ainsworth, K; Sharp, T; Smith, SE | 1 |
| Duman, RS; Eisch, AJ; Malberg, JE; Nestler, EJ | 1 |
| Ginovart, N; Houle, S; Hussey, D; Meyer, JH; Wilson, AA | 1 |
| Kato, S; Nisijima, K; Shioda, K; Yoshino, T | 1 |
| Carey, GJ; Gold, LH; Nielsen, DM | 1 |
| Gebicke-Haerter, PJ; Henn, FA; Rapp, S; Thome, J; Zink, M | 1 |
| Khundakar, AA; Zetterström, TSC | 1 |
| Gross, G; Groth, I; Jongen-Relo, A; Rex, A; Wicke, KM | 1 |
| Bylund, DB; Happe, HK; Petty, F; Reed, AL | 1 |
| Benekareddy, M; Dias, BG; Kulkarni, VA; Mehrotra, P; Ramakrishnan, P; Vaidya, VA | 1 |
| Gorzalka, BB; Hill, MN; Hillard, CJ; Ho, WS | 1 |
| Han, YS; Lee, CS | 1 |
| Bleich, S; Frieling, H; Herbst, D; Nedeljkov, V; Nedeljkov-Jancic, R; Pavlovic, D; Ribback, S; Wendt, M | 1 |
| Kasai, M; Kato, S; Nisijima, K; Shioda, K; Yoshino, T | 1 |
| Cho, HY; Kim, JE; Kim, YH; Lee, BJ; Lee, CH; Lee, JG; Park, SW; Seo, MK; Seol, W | 1 |
| Bielecka, AM; Obuchowicz, E | 1 |
| Akinci, M; Canbaz, S; Gunduz, O; Huseyin, S; Karadag, CH; Oltulu, C; Topuz, RD | 1 |
1 review(s) available for tranylcypromine and fluoxetine
| Article | Year |
|---|---|
Possible monoamine oxidase inhibitor-serotonin uptake inhibitor interaction: fluoxetine clinical data and preclinical findings.
Topics: Adult; Aged; Brain; Depressive Disorder; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Interactions; Drug Therapy, Combination; Fatal Outcome; Female; Fluoxetine; Humans; Male; Middle Aged; Monoamine Oxidase Inhibitors; Neurologic Examination; Phenelzine; Product Surveillance, Postmarketing; Receptors, Serotonin; Tranylcypromine | 1993 |
1 trial(s) available for tranylcypromine and fluoxetine
| Article | Year |
|---|---|
Pharmacological treatment of kleptomania and bulimia nervosa.
Topics: Adult; Bulimia; Clinical Trials as Topic; Disruptive, Impulse Control, and Conduct Disorders; Drug Therapy, Combination; Female; Fluoxetine; Follow-Up Studies; Humans; Tranylcypromine; Trazodone | 1989 |
33 other study(ies) available for tranylcypromine and fluoxetine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship | 2012 |
The effects of serotonergic stimulation on hippocampal and neocortical slow waves and behavior.
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Benserazide; Cerebral Cortex; Electroencephalography; Fluoxetine; Hippocampus; Male; Metergoline; Motor Activity; p-Chloroamphetamine; Rats; Scopolamine; Serotonin; Serotonin Antagonists; Stereotyped Behavior; Tranylcypromine; Tryptophan | 1991 |
Fluoxetine ingestion: a one year retrospective study.
Topics: Accidents; Adolescent; Adult; Child; Child, Preschool; Drug Interactions; Environmental Exposure; Fluoxetine; Humans; Infant; Middle Aged; Retrospective Studies; Suicide, Attempted; Time Factors; Tranylcypromine | 1990 |
Adverse consequences of fluoxetine-MAOI combination therapy.
Topics: Adult; Akathisia, Drug-Induced; Confusion; Depressive Disorder; Drug Interactions; Drug Therapy, Combination; Female; Fluoxetine; Humans; Male; Monoamine Oxidase Inhibitors; Myoclonus; Phenelzine; Tranylcypromine; Tremor | 1990 |
Danger of MAOI therapy after fluoxetine withdrawal.
Topics: Adult; Drug Administration Schedule; Drug Interactions; Female; Fluoxetine; Humans; Substance Withdrawal Syndrome; Tranylcypromine | 1988 |
The stereoselectivity of serotonin uptake in brain tissue and blood platelets: the topography of the serotonin uptake area.
Topics: Alanine; Amphetamine; Aniline Compounds; Animals; Antidepressive Agents; Blood Platelets; Brain; Fluoxetine; Humans; Male; Methadone; Mianserin; Mirtazapine; Morpholines; Naphthalenes; Nefopam; Nomifensine; Paroxetine; Piperidines; Rabbits; Serotonin; Stereoisomerism; Tranylcypromine; Viloxazine; Zimeldine | 1986 |
Manipulations of 5-HT activity and memory in the rat.
Topics: 5-Hydroxytryptophan; Animals; Avoidance Learning; Drug Interactions; Fenfluramine; Fluoxetine; Imipramine; Lithium; Male; Memory; Rats; Rats, Inbred Strains; Serotonin; Serotonin Antagonists; Tranylcypromine | 1985 |
In vivo pharmacological studies on the interactions between tryptamine and 5-hydroxytryptamine.
Topics: 5-Hydroxytryptophan; Animals; Behavior, Animal; Chickens; Deglutition; Female; Fluoxetine; Levodopa; Male; Mice; p-Chloroamphetamine; Rats; Serotonin; Tranylcypromine; Tryptamines | 1981 |
Reduction of responses to angiotensin II by antidepressant drugs.
Topics: Acetylcholine; Analysis of Variance; Angiotensin II; Animals; Antidepressive Agents; Binding, Competitive; Cocaine; Desipramine; Drinking; Drug Interactions; Female; Fluoxetine; In Vitro Techniques; Isoproterenol; Male; Oxytocin; Rats; Rats, Wistar; Tranylcypromine; Uterine Contraction; Uterus | 1994 |
Fluoxetine and the serotonin syndrome.
Topics: Akathisia, Drug-Induced; Confusion; Drug Therapy, Combination; Emergency Medicine; Fluoxetine; Humans; Male; Middle Aged; Muscle Rigidity; Sweating; Syndrome; Tranylcypromine | 1994 |
Chronic antidepressant administration increases the expression of cAMP response element binding protein (CREB) in rat hippocampus.
Topics: 1-Naphthylamine; Animals; Antidepressive Agents; Base Sequence; Blotting, Northern; Brain-Derived Neurotrophic Factor; Cyclic AMP Response Element-Binding Protein; Desipramine; Electric Stimulation; Fluoxetine; Hippocampus; Imipramine; In Situ Hybridization; Male; Molecular Sequence Data; Nerve Growth Factors; Nerve Tissue Proteins; Phosphodiesterase Inhibitors; Pyrrolidinones; Rats; Rats, Sprague-Dawley; Receptor Protein-Tyrosine Kinases; Receptor, trkB; Receptors, Nerve Growth Factor; RNA, Messenger; Rolipram; Sertraline; Time Factors; Tranylcypromine | 1996 |
Sensitive measurement of agonist-stimulated [3H]inositol monophosphate accumulation in rat cortical miniprisms.
Topics: Animals; Carbachol; Cerebral Cortex; Fenfluramine; Fluoxetine; Histological Techniques; Inositol Phosphates; Male; Monoamine Oxidase Inhibitors; Neurology; Rats; Rats, Sprague-Dawley; Sensitivity and Specificity; Serotonin; Serotonin Agents; Tranylcypromine; Tritium | 1997 |
Evidence of a possible role of altered angiotensin function in the treatment, but not etiology, of depression.
Topics: Adult; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Binding Sites; Cell Culture Techniques; Depression, Postpartum; Desipramine; Disease Models, Animal; Female; Fluoxetine; Humans; Losartan; Male; Mice; Receptors, Angiotensin; Tranylcypromine | 1999 |
cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Antipsychotic Agents; beta-Galactosidase; Brain Chemistry; Cocaine; Coloring Agents; Cyclic AMP Response Element-Binding Protein; Desipramine; Dopamine Uptake Inhibitors; Fluoxetine; Haloperidol; Lac Operon; Mice; Mice, Transgenic; Monoamine Oxidase Inhibitors; Phosphorylation; Transcription, Genetic; Tranylcypromine; Up-Regulation | 2000 |
Selective increase of dopamine D3 receptor gene expression as a common effect of chronic antidepressant treatments.
Topics: Amitriptyline; Animals; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Desipramine; Dopamine; Dynorphins; Electroshock; Fluoxetine; Gene Expression; Imipramine; Islands of Calleja; Limbic System; Male; Monoamine Oxidase Inhibitors; Nucleus Accumbens; Rats; Rats, Wistar; Receptors, Dopamine D2; Receptors, Dopamine D3; RNA, Messenger; Substance P; Tranylcypromine | 2000 |
Repeated administration of fluoxetine, desipramine and tranylcypromine increases dopamine D2-like but not D1-like receptor function in the rat.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Apomorphine; Behavior, Animal; Benzazepines; Desipramine; Dopamine Agonists; Fluoxetine; Male; Phenethylamines; Quinpirole; Rats; Rats, Sprague-Dawley; Receptors, Dopamine D1; Receptors, Dopamine D2; Tranylcypromine | 1998 |
Chronic antidepressant treatment increases neurogenesis in adult rat hippocampus.
Topics: Animals; Antidepressive Agents; Antigens, Differentiation; Bromodeoxyuridine; Cell Count; Cell Division; Cell Survival; Fluorescent Antibody Technique; Fluoxetine; Hippocampus; Male; Morpholines; Neurons; Rats; Rats, Sprague-Dawley; Reboxetine; Tranylcypromine | 2000 |
[11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats.
Topics: Adrenergic Uptake Inhibitors; Animals; Benzylamines; Brain; Carrier Proteins; Cats; Citalopram; Dopamine Antagonists; Fluoxetine; Haloperidol; Maprotiline; Membrane Glycoproteins; Membrane Transport Proteins; Monoamine Oxidase Inhibitors; Nerve Tissue Proteins; Piperazines; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Plasma Membrane Transport Proteins; Time Factors; Tissue Distribution; Tomography, Emission-Computed; Tranylcypromine | 2003 |
Extracellular serotonin, dopamine and glutamate levels are elevated in the hypothalamus in a serotonin syndrome animal model induced by tranylcypromine and fluoxetine.
Topics: Animals; Antidepressive Agents; Biogenic Monoamines; Body Temperature; Dopamine; Extracellular Fluid; Fever; Fluoxetine; Glutamic Acid; Hypothalamus; Male; Microdialysis; Rats; Rats, Wistar; Selective Serotonin Reuptake Inhibitors; Serotonin; Serotonin Syndrome; Tranylcypromine | 2004 |
Antidepressant-like activity of corticotropin-releasing factor type-1 receptor antagonists in mice.
Topics: Animals; Antidepressive Agents; Clorgyline; Desipramine; Dose-Response Relationship, Drug; Fluoxetine; Hindlimb Suspension; Male; Mice; Morpholines; Motor Activity; Paroxetine; Pyrazoles; Pyrimidines; Pyrroles; Reboxetine; Receptors, Corticotropin-Releasing Hormone; Selegiline; Swimming; Tranylcypromine; Triazines | 2004 |
Antidepressants differentially affect expression of complexin I and II RNA in rat hippocampus.
Topics: Adaptor Proteins, Vesicular Transport; Animals; Antidepressive Agents; Brain Mapping; Desipramine; Fluoxetine; Gene Expression; Hippocampus; Injections, Intraperitoneal; Male; Nerve Tissue Proteins; Rats; Rats, Sprague-Dawley; RNA, Messenger; Syntaxin 1; Transcription, Genetic; Tranylcypromine | 2005 |
Biphasic change in BDNF gene expression following antidepressant drug treatment explained by differential transcript regulation.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Brain; Brain Chemistry; Brain-Derived Neurotrophic Factor; Depressive Disorder; Desipramine; Drug Administration Schedule; Electroshock; Exons; Fluoxetine; Gene Expression Regulation; Male; Monoamine Oxidase Inhibitors; Rats; Rats, Sprague-Dawley; Regulatory Elements, Transcriptional; RNA, Messenger; Transcriptional Activation; Tranylcypromine; Up-Regulation | 2006 |
The guinea pig forced swim test as a new behavioral despair model to characterize potential antidepressants.
Topics: Amitriptyline; Animals; Antidepressive Agents; Antidepressive Agents, Tricyclic; Antipsychotic Agents; Behavior, Animal; Central Nervous System Stimulants; Clozapine; Desipramine; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drugs, Investigational; Fluoxetine; Guinea Pigs; Injections, Intraperitoneal; Male; Methamphetamine; Monoamine Oxidase Inhibitors; Paroxetine; Piperidines; Selective Serotonin Reuptake Inhibitors; Swimming; Tranylcypromine | 2007 |
Juvenile rats in the forced-swim test model the human response to antidepressant treatment for pediatric depression.
Topics: Adolescent; Age Factors; Animals; Antidepressive Agents; Child; Citalopram; Depressive Disorder; Desipramine; Disease Models, Animal; Escape Reaction; Fluoxetine; Helplessness, Learned; Humans; Imipramine; Injections, Intraperitoneal; Male; Motivation; Rats; Rats, Sprague-Dawley; Swimming; Tranylcypromine | 2008 |
Antidepressant treatments regulate matrix metalloproteinases-2 and -9 (MMP-2/MMP-9) and tissue inhibitors of the metalloproteinases (TIMPS 1-4) in the adult rat hippocampus.
Topics: Animals; Antidepressive Agents; Desipramine; Drug Administration Schedule; Electroconvulsive Therapy; Extracellular Matrix; Fluoxetine; Hippocampus; Male; Matrix Metalloproteinase 2; Matrix Metalloproteinase 9; Neuronal Plasticity; Rats; Rats, Sprague-Dawley; RNA, Messenger; Tissue Inhibitor of Metalloproteinases; Tranylcypromine | 2008 |
Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents.
Topics: Animals; Antidepressive Agents; Arachidonic Acids; Binding, Competitive; Biogenic Monoamines; Brain; Cannabinoid Receptor Modulators; Depressive Disorder; Endocannabinoids; Fluoxetine; Glycerides; Ligands; Limbic System; Male; Monoamine Oxidase Inhibitors; Polyunsaturated Alkamides; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Selective Serotonin Reuptake Inhibitors; Synaptic Transmission; Tranylcypromine; Up-Regulation | 2008 |
Antidepressants reveal differential effect against 1-methyl-4-phenylpyridinium toxicity in differentiated PC12 cells.
Topics: 1-Methyl-4-phenylpyridinium; Amitriptyline; Animals; Antidepressive Agents; Apoptosis; Cell Culture Techniques; Cell Differentiation; Cell Nucleus; Cell Survival; DNA Fragmentation; Fluoxetine; Membrane Potential, Mitochondrial; Mitochondrial Membranes; Oxidative Stress; PC12 Cells; Permeability; Rats; Tranylcypromine | 2009 |
Effects of amitriptyline, fluoxetine, tranylcypromine and venlafaxine on rat vascular smooth muscle in vitro--the role of the endothelium.
Topics: Amitriptyline; Animals; Antidepressive Agents; Aorta, Abdominal; Aorta, Thoracic; Cyclic AMP; Cyclic GMP; Cyclohexanols; Dinoprost; Endothelium, Vascular; Fluoxetine; In Vitro Techniques; Muscle Contraction; Muscle, Smooth; Nitric Oxide; Phenylephrine; Potassium Channel Blockers; Potassium Chloride; Rats; Rats, Inbred Lew; Selective Serotonin Reuptake Inhibitors; Tranylcypromine; Venlafaxine Hydrochloride | 2012 |
Risperidone attenuates the increase of extracellular nitric oxide and glutamate levels in serotonin syndrome animal models.
Topics: 5-Hydroxytryptophan; Animals; Brain; Clorgyline; Disease Models, Animal; Fluoxetine; Glutamic Acid; Male; Microdialysis; Monoamine Oxidase Inhibitors; Nitric Oxide; Rats, Wistar; Risperidone; Selective Serotonin Reuptake Inhibitors; Serotonin Antagonists; Serotonin Syndrome; Tranylcypromine | 2012 |
Effects of antidepressant drugs on synaptic protein levels and dendritic outgrowth in hippocampal neuronal cultures.
Topics: Animals; Antidepressive Agents; Antidepressive Agents, Second-Generation; Antidepressive Agents, Tricyclic; Cell Enlargement; Cells, Cultured; Citalopram; Dendrites; Fluoxetine; Hippocampus; Imipramine; Nerve Tissue Proteins; Neurons; Paroxetine; Rats; Rats, Sprague-Dawley; Sertraline; Thiazepines; Tranylcypromine | 2014 |
Antidepressant drugs can modify cytotoxic action of temozolomide.
Topics: Antidepressive Agents; Antineoplastic Agents, Alkylating; Apoptosis; Brain Neoplasms; Cell Division; Cell Line, Tumor; Cell Survival; Dacarbazine; Depression; Drug Interactions; Fluoxetine; Glioblastoma; Humans; Imipramine; Temozolomide; Tranylcypromine; Tumor Hypoxia | 2017 |
Effects of in vitro Amitriptyline, Fluoxetine, Tranylcypromine and Venlafaxine on Saphenous Vein Grafts.
Topics: Aged; Aged, 80 and over; Amitriptyline; Analysis of Variance; Antidepressive Agents; Coronary Artery Bypass; Endothelium, Vascular; Female; Fluoxetine; Humans; Male; Middle Aged; Muscle, Smooth, Vascular; Reference Values; Saphenous Vein; Transplants; Tranylcypromine; Vasodilation; Venlafaxine Hydrochloride | 2019 |